A detailed history of Sargent Bickham Lagudis LLC transactions in Stryker Corp stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 22,832 shares of SYK stock, worth $8.79 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
22,832
Previous 23,025 0.84%
Holding current value
$8.79 Million
Previous $4.66 Million 19.66%
% of portfolio
0.46%
Previous 0.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

SELL
$205.51 - $253.93 $39,663 - $49,008
-193 Reduced 0.84%
22,832 $0
Q3 2022

Oct 27, 2022

BUY
$189.27 - $231.83 $31,040 - $38,020
164 Added 0.72%
23,025 $4.66 Million
Q2 2022

Jul 13, 2022

BUY
$194.09 - $276.37 $29,501 - $42,008
152 Added 0.67%
22,861 $4.55 Million
Q1 2022

Apr 27, 2022

SELL
$245.33 - $277.77 $673,430 - $762,478
-2,745 Reduced 10.78%
22,709 $6.07 Million
Q4 2021

Jan 18, 2022

SELL
$236.63 - $276.44 $256,033 - $299,108
-1,082 Reduced 4.08%
25,454 $6.81 Million
Q3 2021

Nov 05, 2021

BUY
$248.9 - $280.09 $8,462 - $9,523
34 Added 0.13%
26,536 $7 Million
Q2 2021

Jul 19, 2021

SELL
$242.95 - $267.0 $167,878 - $184,497
-691 Reduced 2.54%
26,502 $6.88 Million
Q1 2021

May 24, 2021

BUY
$221.01 - $248.82 $15,912 - $17,915
72 Added 0.27%
27,193 $6.62 Million
Q4 2020

May 24, 2021

SELL
$202.01 - $245.04 $14,544 - $17,642
-72 Reduced 0.26%
27,121 $6.65 Million
Q4 2020

May 24, 2021

SELL
$202.01 - $245.04 $251,300 - $304,829
-1,244 Reduced 4.37%
27,193 $6.62 Million
Q3 2020

Sep 01, 2021

BUY
$177.77 - $215.81 $120,172 - $145,887
676 Added 2.44%
28,437 $5.93 Million
Q2 2020

Sep 07, 2021

BUY
$144.67 - $207.03 $104,451 - $149,475
722 Added 2.67%
27,761 $5 Million
Q1 2020

Sep 07, 2021

BUY
$126.5 - $225.1 $685,630 - $1.22 Million
5,420 Added 25.07%
27,039 $4.5 Million
Q4 2019

Sep 14, 2021

SELL
$197.98 - $220.53 $80,775 - $89,976
-408 Reduced 1.85%
21,619 $4.54 Million
Q3 2019

Sep 14, 2021

SELL
$205.4 - $221.82 $454,961 - $491,331
-2,215 Reduced 9.14%
22,027 $4.77 Million
Q2 2019

Sep 13, 2021

SELL
$180.24 - $205.58 $7,750 - $8,839
-43 Reduced 0.18%
24,242 $4.98 Million
Q1 2019

Sep 13, 2021

SELL
$152.46 - $198.0 $132,945 - $172,656
-872 Reduced 3.47%
24,285 $4.8 Million
Q4 2018

Sep 13, 2021

BUY
$145.0 - $178.65 $51,620 - $63,599
356 Added 1.44%
25,157 $3.94 Million
Q3 2018

Sep 13, 2021

BUY
$163.25 - $177.68 $7,836 - $8,528
48 Added 0.19%
24,801 $4.41 Million
Q2 2018

Sep 13, 2021

SELL
$155.17 - $179.78 $175,342 - $203,151
-1,130 Reduced 4.37%
24,753 $4.18 Million
Q1 2018

Sep 13, 2021

BUY
$148.01 - $168.91 $115,595 - $131,918
781 Added 3.11%
25,883 $4.17 Million
Q4 2017

Sep 13, 2021

BUY
$143.51 - $159.74 $100,313 - $111,658
699 Added 2.86%
25,102 $3.89 Million
Q3 2017

Sep 13, 2021

BUY
$138.36 - $147.87 $12,175 - $13,012
88 Added 0.36%
24,403 $3.47 Million
Q2 2017

Sep 13, 2021

SELL
N/A
-489 Reduced 1.97%
24,315 $3.37 Million
Q1 2017

Sep 13, 2021

BUY
N/A
697 Added 2.89%
24,804 $3.27 Million
Q4 2016

Sep 13, 2021

BUY
N/A
21,039 Added 685.76%
24,107 $2.89 Million
Q3 2016

Sep 13, 2021

SELL
N/A
-903 Reduced 22.74%
3,068 $357,000
Q2 2016

Sep 07, 2021

BUY
N/A
269 Added 7.27%
3,971 $476,000
Q1 2016

Sep 07, 2021

BUY
N/A
3,702
3,702 $397,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $146B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.